The Readout Loud
STAT
STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.
Episodes
Mentioned books
Dec 6, 2018 • 23min
Episode 39: Using the word 'cure,' an FDA loophole, & making biotech history
Can gene therapy cure sickle cell disease? Is an expensive drug better than a free one? And will biotech see its shadow in 2019?
Nov 29, 2018 • 24min
Episode 38: Your guide to the #CRISPRbabies controversy
What does it mean to edit a person? Has science run afoul of basic ethics? And what's the time difference to Hong Kong?
Nov 15, 2018 • 26min
Episode 37: The biggest-ever IPO, drug prices rising in tandem, and burner Twitter accounts
Can unicorns float? Is a hot dog a sandwich? And how are drug companies like gas stations?
Nov 8, 2018 • 23min
Episode 36: What the midterms mean, a golden age on hold, and the $4 million drug
Is pharma in for a swarm of subpoenas? Are we running out of ideas in oncology? And can a drug possibly be worth $4 million a dose?
Nov 1, 2018 • 26min
Episode 35: Biotech's October slump, the precise cost of precision, and breaking postpartum silence
Why are biotech stocks in the dumps? Is the latest in cancer care overhyped? And what does "folie à deux" mean?
Oct 25, 2018 • 22min
Episode 34: Pharma at the ballot box, the latest Alzheimer's argument, and a rare disease dilemma
Can pharma-shaming get someone re-elected? How rare is too rare when it comes to biotech research? And what does "positive" even mean, really?
Oct 18, 2018 • 25min
Episode 33: Drug prices on TV, immortal blockbusters, and genetic privacy
Are prescription drugs like new cars? Is pharma's grand bargain a sham? And who keeps your DNA safe?
Oct 11, 2018 • 23min
Episode 32: Fake friends at the FDA, cancer counter-narratives, and biotech's bear turn
Is the next big idea in oncology a bust? What does "successful" mean exactly? And why does Wall Street hate biotech all of a sudden?
Oct 4, 2018 • 24min
Episode 31: Nobel snubs, millenial founders, and a new kind of lightning round
Did the Nobel Prizes go to the right scientists? Why is there so much disdain for biotech's millenial entrepreneurs? And do journalists have a good taste in '80s music?
Sep 27, 2018 • 25min
Episode 30: A fish oil epiphany, VC monopolies and ketamine clinics
Was everyone wrong about fish oil? Is venture capital a cartel? And what's with all those ketamine clinics?
